Shanghai RAAS Blood Products Co., Ltd. (SHE: 002252)
China
· Delayed Price · Currency is CNY
7.22
0.00 (0.00%)
Dec 20, 2024, 3:04 PM CST
Shanghai RAAS Blood Products Revenue
Shanghai RAAS Blood Products had revenue of 2.06B CNY in the quarter ending September 30, 2024, with 1.34% growth. This brings the company's revenue in the last twelve months to 8.34B, up 10.49% year-over-year. In the year 2023, Shanghai RAAS Blood Products had annual revenue of 7.96B with 21.27% growth.
Revenue (ttm)
8.34B
Revenue Growth
+10.49%
P/S Ratio
5.74
Revenue / Employee
2.56M
Employees
3,254
Market Cap
47.69B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.96B | 1.40B | 21.27% |
Dec 31, 2022 | 6.57B | 2.28B | 53.16% |
Dec 31, 2021 | 4.29B | 1.53B | 55.26% |
Dec 31, 2020 | 2.76B | 176.70M | 6.84% |
Dec 31, 2019 | 2.58B | 780.75M | 43.27% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.93B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |